Corneal astigmatism and HOAs affect IOL performance

Article

Uncorrected corneal astigmatism and higher-order aberrations (HOAs) in pseudophakic eyes significantly affects through-focus performance of presbyopia-correcting IOLs.

Uncorrected corneal astigmatism and higher-order aberrations (HOAs) in pseudophakic eyes significantly affects through-focus performance of presbyopia-correcting IOLs.

Dr Len Zhelezynak and his team, Flaum Eye Institute, University of Rochester, Rochester, New York, USA, conducted an experimental study on the impact of corneal aberrations on the through-focus image quality of presbyopia-correcting IOLs using an adaptive optics IOL metrology system.

The device was used to induce corneal astigmatism and HOAs and the image-capturing system acquired through-focus images of a letter chart with 3.0 mm and 5.0 mm pupil diameters.

A single-optic accommodating IOL, an apodized diffractive multifocal IOL, a full-aperture diffractive multifocal IOL and a monofocal IOL were assessed. The correlation-coefficient image-quality metric was used to quantify image quality.

The single-optic accommodating IOL produced a better intermediate image quality, compared to the monofocal IOL. Corneal astigmatism reduced the through-focus quality and depth of focus with all IOLs, but the multifocal IOL had the more significant reduction in depth of focus.

The abstract is available in the Journal of Cataract and Refractive Surgery.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.